Naropin



Indications and Reactions:

Role Indications Reactions
Primary
Epidural Anaesthesia 17.8%
Anaesthesia 11.9%
Nerve Block 9.7%
Local Anaesthesia 9.3%
General Anaesthesia 8.8%
Spinal Anaesthesia 7.4%
Musculoskeletal Pain 5.2%
Analgesia 4.7%
Postoperative Analgesia 4.7%
Maintenance Of Anaesthesia 2.9%
Analgesic Therapy 2.8%
Pain 2.2%
Induction Of Anaesthesia 2.1%
Fluid Replacement 1.7%
Labour Pain 1.6%
Prophylaxis 1.6%
Surgery 1.6%
Caesarean Section 1.4%
Infection Prophylaxis 1.4%
Osteoarthritis 1.4%
Sensory Disturbance 9.0%
Renal Failure Acute 8.3%
Musculoskeletal Pain 7.7%
Overdose 7.7%
Anaphylactic Shock 7.1%
Muscular Weakness 6.4%
Cauda Equina Syndrome 5.8%
Grand Mal Convulsion 4.5%
Neurotoxicity 4.5%
Paraplegia 4.5%
Sensorimotor Disorder 4.5%
Adverse Drug Reaction 3.8%
Convulsion 3.8%
Death 3.8%
Drug Effect Decreased 3.8%
Paralysis 3.8%
Movement Disorder 3.2%
Circulatory Collapse 2.6%
Diplegia 2.6%
Drug Ineffective 2.6%
Secondary
Drug Use For Unknown Indication 13.3%
Epidural Anaesthesia 12.0%
Anaesthesia 11.1%
General Anaesthesia 9.2%
Product Used For Unknown Indication 9.0%
Pain 7.8%
Premedication 7.0%
Analgesia 4.4%
Local Anaesthesia 3.4%
Postoperative Analgesia 2.8%
Preoperative Care 2.6%
Nerve Block 2.5%
Spinal Anaesthesia 2.5%
Caesarean Section 2.3%
Musculoskeletal Pain 2.3%
Analgesic Therapy 1.9%
Back Pain 1.5%
Epidural Test Dose 1.5%
Neuromuscular Blocking Therapy 1.5%
Prophylaxis 1.5%
Renal Failure Acute 16.1%
Sensorimotor Disorder 9.2%
Staphylococcal Infection 9.2%
Paraplegia 8.6%
Grand Mal Convulsion 5.2%
Sensory Disturbance 4.6%
Axonal Neuropathy 4.0%
Cauda Equina Syndrome 4.0%
Muscular Weakness 4.0%
Neuropathy Peripheral 4.0%
Anaphylactic Shock 3.4%
Delayed Recovery From Anaesthesia 3.4%
Nerve Injury 3.4%
Rotator Cuff Syndrome 3.4%
Somnolence 3.4%
Dyspnoea 2.9%
Intervertebral Disc Protrusion 2.9%
Musculoskeletal Pain 2.9%
Shock 2.9%
Convulsion 2.3%
Concomitant
Pain 9.9%
Surgery 8.2%
Nausea 7.9%
Hypertension 7.3%
Wound Complication 6.5%
Anaesthesia 5.9%
Thrombosis Prophylaxis 5.9%
Constipation 5.6%
Sedation 5.1%
Insomnia 4.5%
Antibiotic Prophylaxis 4.2%
Fluid Replacement 3.7%
Analgesic Therapy 3.4%
Convulsion Prophylaxis 3.4%
Infection 3.4%
Rectal Cancer 3.4%
Cerebral Infarction 3.1%
Drug Use For Unknown Indication 3.1%
Induction Of Anaesthesia 3.1%
Blood Pressure Management 2.3%
Death 11.5%
Arrhythmia 9.6%
Wound Secretion 7.7%
Deep Vein Thrombosis 5.8%
Sepsis 5.8%
Stevens-johnson Syndrome 5.8%
Tachycardia 5.8%
Vasculitis 5.8%
Vomiting 5.8%
Wheezing 5.8%
Altered State Of Consciousness 3.8%
Coagulation Factor Increased 3.8%
Delayed Recovery From Anaesthesia 3.8%
Off Label Use 3.8%
Thrombophlebitis Superficial 3.8%
Visual Acuity Reduced 3.8%
Amnesia 1.9%
Anaphylactic Shock 1.9%
Concomitant Disease Progression 1.9%
Delirium 1.9%
Interacting
Thoracic Vertebral Fracture 30.8%
Atrial Fibrillation 23.1%
General Anaesthesia 15.4%
Hypertension 15.4%
Anaesthesia 7.7%
Induction Of Anaesthesia 7.7%
Cardiac Disorder 50.0%
Drug Interaction 50.0%